Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 17 November, 2020

Irish Takeover Panel

Disclosure Table

RNS Number : 5779F
Irish Takeover Panel
17 November 2020
 

IRISH TAKEOVER PANEL       
Disclosure Table  

The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:

___________________________________________________________

 

Offeree:   Osmotica Pharamaceuticals plc

Offer period commenced: - 10 November 2020

US$0.01 ordinary shares; ISIN: IE00BF2HDL56; NSI:62,585,832

Offeror:   No named offeror

Offeree:   CPL Resources plc

Offer period commenced: - 4 November 2020

€0.10 ordinary shares; ISIN: IE0007214426; NSI:27,745,935

Offeror:   Outsourcing Talent Ireland Ltd., a wholly owned subsidiary of  OUTSOURCING Inc.

Disclosure of interests and dealings in the relevant securities of the above offeror is not required.

Offeree:   Willis Towers Watson plc

Offer period commenced: - 9 March 2020

US$0.000304635 ordinary shares ; ISIN: IE00BDB6Q211; NSI:128,905,424

Offeror:   Aon plc

US$0.01 ordinary shares; ISIN: IE00BLP1HW54; NSI: 228,191,340 

 

___________________________________________________________

 

 

 

 

Irish Takeover Panel  17 November 2020

Lower Ground Floor

76 Merrion Square

Dublin D02 NY76

 

Telephone:  + 353-1-678 9020 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEGCBDBUDBDGGR

a d v e r t i s e m e n t